Inflammatory Response: Clinical Trials

10 trials for Inflammatory Response, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 1 not yet recruiting, 1 recruiting, 1 unknown. 10 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 210Completed 7, Not yet recruiting 1, Recruiting 1, Unknown 1
Phase 11Completed 1

Follow Inflammatory Response: new trials by email Literature Review of Inflammatory Response trials Research Report on Inflammatory Response

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Reduction of SystemiC Inflammation After Ischemic Stroke by Intravenous DNase Administration (ReSCInD)
Dornase Alfa, Isotonic Saline Solution - Ischemic Stroke, Inflammatory Response
Phase 2RecruitingLudwig-Maximilians - University of Munich362026-10-012026-09-11
Endotoxin Exposure to Examine the Role of Inflammation in Alcohol Use
Endotoxin, Placebo saline - Alcohol Use Disorder, Inflammatory Response
Phase 2Not yet recruitingUniversity of California, Los Angeles642026-09-012026-08-28
Pulse Glucocorticoid Therapy in Patients With ST-Segment Elevation Myocardial Infarction
Methylprednisolone, Isotonic saline - ST Elevation Myocardial Infarction, Inflammatory Response
Phase 2CompletedThomas Engstrom5302022-11-142026-03-27
Thymol on Netrin-1 on Obese Patients
Thymol - Inflammatory Response, Obesity
Phase 2UnknownCentro Universitario de Ciencias de la Salud, Mexico302022-04-012022-06-22
An Inflammatory Challenge Using Endotoxin
Placebo, Endotoxin - Alcohol Use Disorder, Inflammatory Response
Phase 2CompletedUniversity of California, Los Angeles202021-10-192025-05-01
Asses the Anti-inflammatory Effects of Short Term Copaxone Therapy on Patients the Acute Decompensated Heart Failure
Copaxone, guideline directed medical therapy (GDMT) - Acute Decompensated Heart Failure, Cytokine Storm
Phase 2CompletedHadassah Medical Organization142021-01-042023-08-22
An Investigation on the Effects of Icosapent Ethyl (VascepaTM) on Inflammatory Biomarkers in Individuals With COVID-19
Icosapent ethyl - COVID-19, Inflammatory Response
Phase 2CompletedCanadian Medical and Surgical Knowledge Translation Research Group1002020-06-042021-12-22
Effects of Metformin in a Non-Diabetic Patient Population
MetFORMIN Hydrochloride ER, Placebo - Inflammatory Response
Phase 1 / Phase 2CompletedBrian Zuckerbraun322019-01-222023-01-11
Tramadol Versus Lidocaine Infiltration for Tonsillectomy
peritonsillar infiltration - Peri-tonsillar Analgesic Infiltration, Tonsillectomy
Phase 2CompletedImam Abdulrahman Bin Faisal University902011-12-012014-03-18
Immune Effects of Vitamin D in Hemodialysis Patients
paricalcitol - End Stage Renal Disease, Hemodialysis
Phase 2CompletedRenal Research Institute202004-12-012009-05-13

Narrower conditions

Alcoholism (2)  ·  COVID-19 (1)  ·  Cardiovascular Diseases (1)  ·  Consciousness Disorders (1)  ·  Cytokine Release Syndrome (1)  ·  Fractures, Stress (1)  ·  Heart Failure (1)  ·  Inflammation (1)  ·  Ischemic Stroke (1)  ·  Kidney Failure, Chronic (1)  ·  Myocardial Reperfusion Injury (1)  ·  Obesity (1)  ·  Pain, Postoperative (1)  ·  Reperfusion Injury (1)  ·  ST Elevation Myocardial Infarction (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (6)  ·  Cardiovascular Diseases (4)  ·  Pathologic Processes (4)  ·  Signs and Symptoms (3)  ·  Vascular Diseases (3)  ·  Alcohol-Related Disorders (2)  ·  Chemically-Induced Disorders (2)  ·  Heart Diseases (2)  ·  Mental Disorders (2)  ·  Nervous System Diseases (2)  ·  Neurologic Manifestations (2)  ·  Postoperative Complications (2)  ·  Substance-Related Disorders (2)  ·  Body Weight (1)  ·  Brain Diseases (1)

Interventions

Endotoxins (2)  ·  Sodium Chloride (2)  ·  Glatiramer Acetate (1)  ·  Lipopolysaccharides (1)  ·  Metformin (1)  ·  Methylprednisolone (1)  ·  Methylprednisolone Hemisuccinate (1)  ·  Thymol (1)  ·  dornase alfa (1)  ·  eicosapentaenoic acid ethyl ester (1)  ·  paricalcitol (1)

Sponsors

University of California, Los Angeles (2)  ·  Brian Zuckerbraun (1)  ·  Canadian Medical and Surgical Knowledge Translation Research Group (1)  ·  Centro Universitario de Ciencias de la Salud, Mexico (1)  ·  Hadassah Medical Organization (1)  ·  Imam Abdulrahman Bin Faisal University (1)  ·  Ludwig-Maximilians - University of Munich (1)  ·  Renal Research Institute (1)  ·  Thomas Engstrom (1)

Countries

United States (3)  ·  Canada (1)  ·  Denmark (1)  ·  Germany (1)  ·  Israel (1)  ·  Mexico (1)  ·  Saudi Arabia (1)

Top investigators

Lara Ray, PhD (2)  ·  Abdulhadi Al'Saflan, MD (1)  ·  Alaa M. Khidr, MD (1)  ·  Arthur Liesz, Prof. Dr. (1)  ·  Brian Zuckerbraun, MD (1)  ·  Hany A. Mowafi, MD (1)  ·  Jasmine M Madsen, MD (1)  ·  Maria G Ramos-Zavala, PhD (1)  ·  Nathan W Levin, MD (1)  ·  Offer Amir, PhD (1)  ·  Subodh Verma, MD, PhD (1)

Results publications

PMID 34462732, PMID 39211964, PMID 39869712, PMID 40102868, PMID 40705350

NIH funding

K24AA025704 (1)